Allergan OPTIVE FUSION™ is a dual-polymer synergy uniquely formulated to provide comfortable protection to maintain a healthy tear film and relieve aqueous-deficient dry eye.
The two most sought-after polymers in eye care can now be found in one soothing single-drop formula.
Only OPTIVE FUSION™ combines the properties of Carboxymethylcellulose (CMC) and Hyaluronic Acid (HA) to lubricate, protect, and restore a healthy tear film for instant relief of aqueous-deficient dry eye.
OPTIVE FUSION™ is compatible with contact lenses and can be used for up to three months before discarding.
Soothes the symptoms of DED
Enhances water retention
Stabilises the tear film by providing comfort and lubrication
Improves ocular surface integrity
Long retention time
Helps protect the surface of your eyes by providing hydration
Protects against hyperosmotic stress
Restores osmotic balance
Place one or two drops of OPTIVE FUSION™ in the affected eye(s) as needed.
OPTIVE FUSION™ is supplied in plastic bottles containing 10ml
Higher-viscosity OPTIVE® GEL DROPS are an effective add-on treatment to OPTIVE PLUS™ , providing long-lasting relief both during the day and at night.

OPTIVE FUSION™ Eye Drops and OPTIVE FUSION™ Unit Dose Eye Drops: Contains sodium hyaluronate 1 mg/ml, carboxymethylcellulose sodium 5 mg/ml, and glycerine 9 mg/ml.
OPTIVE® Gel Drops: Contains carboxymethylcellulose sodium 10 mg/ml and glycerine 9 mg/ml.
For full prescribing information, refer to the Instructions for Use.
Allergan Pharmaceuticals (Pty) Ltd, PO Box 6024, Halfway House, 1685, South Africa (Co. Reg. no. 1984/005576/07)
Telephone: +27 (0) 11 545 6600, Facsimile: +27 (0) 11 315 6008
www.allergan.co.za
© 2018. ®/™ Registered Trademark/Trademark of Allergan, Inc. ZA/0104/2018
1. Allergan OPTIVE FUSION™ labelling, 2017. App: Section 5. 1. Jones L et al. Ocul Surf 2017, 15: 575-628
2. Simmons P et al. Clin Ophthalmol. 2015 ;15(9) : 665–675
3. TFOS DEWS II management and therapy report. The Ocular Surface. 2017;15(3): 575–628
4. Sanchez MA et al. Cornea. 2010;29(2): 167–171
5. Baudouin C et al. Ocul Surg. 2013;11: 246–248